Darcy Blankenship, MD
Family Medicine · Wetumpka, ALNPI 1881176964
Payments from drug & device makers
Across 468 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AbbVie$988
- Neurocrine Biosciences, Inc.$909
- Novo Nordisk$791
- AstraZeneca$790
- Lilly USA, LLC$602
- plus $3K from 39 others
What the payments were for
- Food & beverage$8,588100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,588 in reported general payments places this provider in the 85th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 160 | $229,542 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 145 | $106,366 |
| MounjaroTirzepatide | 69 | $79,918 |
| EliquisApixaban | 83 | $73,653 |
| RexultiBrexpiprazole | 28 | $57,597 |
| JardianceEmpagliflozin | 58 | $56,257 |
| FarxigaDapagliflozin Propanediol | 49 | $43,425 |
| MyrbetriqMirabegron | 52 | $42,787 |
| JanuviaSitagliptin Phosphate | 38 | $35,062 |
| LinzessLinaclotide | 24 | $31,303 |
| DovatoDolutegravir Sodium/Lamivudine | 11 | $30,646 |
| VraylarCariprazine Hcl | 16 | $25,611 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 26 | $23,978 |
| Repatha SureclickEvolocumab | 40 | $23,933 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $22,009 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $791 | $229,542160 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $1,063 | $111,940158 claims |
| Lilly USA, LLCMounjaro, Trulicity | $602 | $94,25983 claims |
| PfizerEliquis, Premarin | $564 | $78,70695 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $790 | $65,43476 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $292 | $57,59728 claims |
| AbbVieLinzess, Vraylar | $988 | $56,91440 claims |
| Boehringer IngelheimJardiance | $103 | $56,25758 claims |
| Astellas Pharma US IncMyrbetriq | $129 | $42,78752 claims |
| MerckJanuvia | $32 | $35,06238 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $58 | $23,97826 claims |
| Johnson & JohnsonXarelto | $23 | $21,44119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Wetumpka
- Martin LyonsWetumpka$17K
- Michael VaughnBirmingham$9.9M
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
- Aaron KarrSheffield$3.1M
- Nidal MorrarFoley$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.